Skyrizi (risankizumab-rzaa) is a prescription injection that’s used to treat certain autoimmune disorders, such as plaque psoriasis and Crohn’s disease. Skyrizi comes in a few different forms ...

Patients may self-inject Skyrizi after training in subcutaneous injection technique. In April 2021, the Food and Drug Administration (FDA) approved the supplemental Biologics License Application ...

"That's why we're proud to provide an updated SKYRIZI treatment experience that allows for fewer injections of the same SKYRIZI that patients and providers have come to know and trust." ...

Back to Healio Skyrizi is now available as a single-dose 150 mg injection for the treatment of adults with moderate to severe plaque psoriasis in the United States, AbbVie announced in a press ...